DeuterOncology
clinical-stage drug development company
Total raised
€5.7M
€5,650,000
Funding rounds
1
Investors
3
distinct backers
Active since
2023-01
latest 2023-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-19 | Series A | €5.7M | Investsud Tech,Newton Biocapital,Noshaq | View deal → |
Investors
3Related news
- DeuterOncology Closes €5.65M Series A Financing Roundfinsmes.com · 2023-01
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Kpler€1.0BBelgium · Software